Inflazyme is a brand dedicated to improving the quality of life for millions of people suffering from debilitating inflammatory diseases such as asthma, rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. Their focus is on developing new drug therapies to effectively manage these chronic conditions. Asthma, one of the most common chronic diseases worldwide, affects the airways and causes repeated episodes of wheezing, breathlessness, and coughing.

Inflazyme recognizes that asthma can significantly impact daily activities and the ability to have a good night's sleep. Though there is no known cure for asthma, there are treatments available to manage the symptoms. Currently, the most effective treatments for asthma involve the use of corticosteroids, which reduce inflammation in the airways.

Other control medicines, such as long-acting beta2-agonists and leukotriene modifiers, help relax the airway smooth muscles and suppress airway inflammation. Quick-relief medications, like Albuterol, provide immediate relief during asthmatic episodes. Inflazyme understands the economic and social burden asthma places on individuals and society as a whole.

They strive to alleviate this burden through their innovative products and dedication to advancing asthma treatment